Información de la revista
Más populares
Artículos que han recibido mayor atención en las redes sociales. Número de veces que han sido referenciados en los últimos 3 años.
347
An Integrated Review of the Hepatorenal SyndromeAlicia S. Ojeda-Yuren, Eira Cerda-Reyes, Maria R. Herrero-Maceda, Graciela Castro-Narro, Salvatore Piano
Ann Hepatol. 2021;22C:236
347
Open access
286
Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerationsMaría-Jimena Muciño-Bermejo
Ann Hepatol. 2020;19:145-52
286
Open access
171
Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesisAnkita Chatterjee, Analabha Basu, Kausik Das, Pankaj Singh, Dipankar Mondal, Biswanath Bhattacharya, Shweta Roychoudhury, Partha P. Majumder, ... Priyadarshi Basu
Ann Hepatol. 2020;19:472-81
171
Open access
120
Mediterranean-like mix of fatty acids induces cellular protection on lipid-overloaded hepatocytes from western diet fed miceLyssia Castellanos-Tapia, María Elizabeth Tejero-Barrera, Soraya Salas-Silva, Arturo Simoni-Nieves, Alejandro Escobedo-Calvario, Luis E. Gomez-Quiroz
Ann Hepatol. 2020;19:489-96
120
Open access
87
A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their managementJulio D. Vorobioff, Fernando Contreras, Federico Tanno, Lucía Hernández, Fernando Bessone, Luis Colombato, José Adi, Eduardo Fassio, ... Martín Garzón
Ann Hepatol. 2020;19:396-403
87
Open access
57
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven M. Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, ... NAFLD Nomenclature consensus group
Ann Hepatol. 2024;29:101133
57
Acceso a texto completo
57
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidenceCiro Celsa, Caterina Stornello, Paolo Giuffrida, Carmelo Marco Giacchetto, Mauro Grova, Gabriele Rancatore, Concetta Pitrone, Vito Di Marco, ... Giuseppe Cabibbo
Ann Hepatol. 2022;27 Supl 1:100568
57
Open access
56
Prevalence and impact of Sjögren's syndrome in primary biliary cholangitis: a systematic review and meta-analysisXiaoling Deng, Jiahuan Li, Shuhui Hou, Bai Ci, Beibei Liu, Keshu Xu
Ann Hepatol. 2022;27:100746
56
Acceso a texto completo
45
Bacterial infections in cirrhosis: Current treatmentGodolfino Miranda-Zazueta, Luis A. Ponce de León-Garduño, Jonathan Aguirre-Valadez, Aldo Torre-Delgadillo
Ann Hepatol. 2020;19:238-44
45
Open access
45
Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patientsFabiola López-Bautista, Varenka J. Barbero-Becerra, María Yolanda Ríos, M. Ángeles Ramírez-Cisneros, Cristell A. Sánchez-Pérez, Martha H. Ramos-Ostos, Misael Uribe, Norberto C. Chávez-Tapia, Eva Juárez-Hernández
Ann Hepatol. 2020;19:482-8
45
Open access